A randomized, multi-centre, double-blind, double dummy placebo controlled single-dose cross-over study to demonstrate that 12 and 24 microg of formoterol delivered by Concept1 has a bronchodilator efficacy which is equivalent to the same dose of formoterol delivered by Aerolizer in adult patients with persistent asthma.

Trial Profile

A randomized, multi-centre, double-blind, double dummy placebo controlled single-dose cross-over study to demonstrate that 12 and 24 microg of formoterol delivered by Concept1 has a bronchodilator efficacy which is equivalent to the same dose of formoterol delivered by Aerolizer in adult patients with persistent asthma.

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Mar 2017

At a glance

  • Drugs Formoterol (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 24 Oct 2011 Actual end date (May 2007) added as reported by ClinicalTrials.gov.
    • 14 Jun 2007 Status changed from in progress to completed.
    • 10 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top